Global Ocular Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 81

Published Date: 23 May 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Ocular Gene Therapy market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Ocular Gene Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Ocular Gene Therapy market size and forecasts, in consumption value ($ Million), 2019-2030
Global Ocular Gene Therapy market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Ocular Gene Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Ocular Gene Therapy market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ocular Gene Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ocular Gene Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, MeriaGTx, Regenxbio, GenSight Biologics, Astellas, Neurophth Therapeutics, Innostellar Biotherapeutics, Exegenesis Bio, Zhongyin Technology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Ocular Gene Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Ocular Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Gene Replacement Technology
    Gene Editing Technology
    Others

Market segment by Application
    Hospitals
    Diagnostics Centers
    Research Institutes

Market segment by players, this report covers
    AbbVie
    MeriaGTx
    Regenxbio
    GenSight Biologics
    Astellas
    Neurophth Therapeutics
    Innostellar Biotherapeutics
    Exegenesis Bio
    Zhongyin Technology

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Ocular Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Ocular Gene Therapy, with revenue, gross margin, and global market share of Ocular Gene Therapy from 2019 to 2024.
Chapter 3, the Ocular Gene Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Ocular Gene Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Ocular Gene Therapy.
Chapter 13, to describe Ocular Gene Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Ocular Gene Therapy by Type
        1.3.1 Overview: Global Ocular Gene Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Ocular Gene Therapy Consumption Value Market Share by Type in 2023
        1.3.3 Gene Replacement Technology
        1.3.4 Gene Editing Technology
        1.3.5 Others
    1.4 Global Ocular Gene Therapy Market by Application
        1.4.1 Overview: Global Ocular Gene Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Diagnostics Centers
        1.4.4 Research Institutes
    1.5 Global Ocular Gene Therapy Market Size & Forecast
    1.6 Global Ocular Gene Therapy Market Size and Forecast by Region
        1.6.1 Global Ocular Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Ocular Gene Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Ocular Gene Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Ocular Gene Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Ocular Gene Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Ocular Gene Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Ocular Gene Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 AbbVie
        2.1.1 AbbVie Details
        2.1.2 AbbVie Major Business
        2.1.3 AbbVie Ocular Gene Therapy Product and Solutions
        2.1.4 AbbVie Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 AbbVie Recent Developments and Future Plans
    2.2 MeriaGTx
        2.2.1 MeriaGTx Details
        2.2.2 MeriaGTx Major Business
        2.2.3 MeriaGTx Ocular Gene Therapy Product and Solutions
        2.2.4 MeriaGTx Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 MeriaGTx Recent Developments and Future Plans
    2.3 Regenxbio
        2.3.1 Regenxbio Details
        2.3.2 Regenxbio Major Business
        2.3.3 Regenxbio Ocular Gene Therapy Product and Solutions
        2.3.4 Regenxbio Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Regenxbio Recent Developments and Future Plans
    2.4 GenSight Biologics
        2.4.1 GenSight Biologics Details
        2.4.2 GenSight Biologics Major Business
        2.4.3 GenSight Biologics Ocular Gene Therapy Product and Solutions
        2.4.4 GenSight Biologics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 GenSight Biologics Recent Developments and Future Plans
    2.5 Astellas
        2.5.1 Astellas Details
        2.5.2 Astellas Major Business
        2.5.3 Astellas Ocular Gene Therapy Product and Solutions
        2.5.4 Astellas Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Astellas Recent Developments and Future Plans
    2.6 Neurophth Therapeutics
        2.6.1 Neurophth Therapeutics Details
        2.6.2 Neurophth Therapeutics Major Business
        2.6.3 Neurophth Therapeutics Ocular Gene Therapy Product and Solutions
        2.6.4 Neurophth Therapeutics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Neurophth Therapeutics Recent Developments and Future Plans
    2.7 Innostellar Biotherapeutics
        2.7.1 Innostellar Biotherapeutics Details
        2.7.2 Innostellar Biotherapeutics Major Business
        2.7.3 Innostellar Biotherapeutics Ocular Gene Therapy Product and Solutions
        2.7.4 Innostellar Biotherapeutics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Innostellar Biotherapeutics Recent Developments and Future Plans
    2.8 Exegenesis Bio
        2.8.1 Exegenesis Bio Details
        2.8.2 Exegenesis Bio Major Business
        2.8.3 Exegenesis Bio Ocular Gene Therapy Product and Solutions
        2.8.4 Exegenesis Bio Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Exegenesis Bio Recent Developments and Future Plans
    2.9 Zhongyin Technology
        2.9.1 Zhongyin Technology Details
        2.9.2 Zhongyin Technology Major Business
        2.9.3 Zhongyin Technology Ocular Gene Therapy Product and Solutions
        2.9.4 Zhongyin Technology Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Zhongyin Technology Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Ocular Gene Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Ocular Gene Therapy by Company Revenue
        3.2.2 Top 3 Ocular Gene Therapy Players Market Share in 2023
        3.2.3 Top 6 Ocular Gene Therapy Players Market Share in 2023
    3.3 Ocular Gene Therapy Market: Overall Company Footprint Analysis
        3.3.1 Ocular Gene Therapy Market: Region Footprint
        3.3.2 Ocular Gene Therapy Market: Company Product Type Footprint
        3.3.3 Ocular Gene Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Ocular Gene Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Ocular Gene Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Ocular Gene Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Ocular Gene Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Ocular Gene Therapy Consumption Value by Type (2019-2030)
    6.2 North America Ocular Gene Therapy Market Size by Application (2019-2030)
    6.3 North America Ocular Gene Therapy Market Size by Country
        6.3.1 North America Ocular Gene Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Ocular Gene Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Ocular Gene Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Ocular Gene Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Ocular Gene Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Ocular Gene Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Ocular Gene Therapy Market Size by Country
        7.3.1 Europe Ocular Gene Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Ocular Gene Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Ocular Gene Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Ocular Gene Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Ocular Gene Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Ocular Gene Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Ocular Gene Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Ocular Gene Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Ocular Gene Therapy Market Size by Region
        8.3.1 Asia-Pacific Ocular Gene Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Ocular Gene Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Ocular Gene Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Ocular Gene Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Ocular Gene Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Ocular Gene Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Ocular Gene Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Ocular Gene Therapy Consumption Value by Type (2019-2030)
    9.2 South America Ocular Gene Therapy Consumption Value by Application (2019-2030)
    9.3 South America Ocular Gene Therapy Market Size by Country
        9.3.1 South America Ocular Gene Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Ocular Gene Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Ocular Gene Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Ocular Gene Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Ocular Gene Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Ocular Gene Therapy Market Size by Country
        10.3.1 Middle East & Africa Ocular Gene Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Ocular Gene Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Ocular Gene Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Ocular Gene Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Ocular Gene Therapy Market Drivers
    11.2 Ocular Gene Therapy Market Restraints
    11.3 Ocular Gene Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Ocular Gene Therapy Industry Chain
    12.2 Ocular Gene Therapy Upstream Analysis
    12.3 Ocular Gene Therapy Midstream Analysis
    12.4 Ocular Gene Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Ocular Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Ocular Gene Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Ocular Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Ocular Gene Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. AbbVie Company Information, Head Office, and Major Competitors
 Table 6. AbbVie Major Business
 Table 7. AbbVie Ocular Gene Therapy Product and Solutions
 Table 8. AbbVie Ocular Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. AbbVie Recent Developments and Future Plans
 Table 10. MeriaGTx Company Information, Head Office, and Major Competitors
 Table 11. MeriaGTx Major Business
 Table 12. MeriaGTx Ocular Gene Therapy Product and Solutions
 Table 13. MeriaGTx Ocular Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. MeriaGTx Recent Developments and Future Plans
 Table 15. Regenxbio Company Information, Head Office, and Major Competitors
 Table 16. Regenxbio Major Business
 Table 17. Regenxbio Ocular Gene Therapy Product and Solutions
 Table 18. Regenxbio Ocular Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. GenSight Biologics Company Information, Head Office, and Major Competitors
 Table 20. GenSight Biologics Major Business
 Table 21. GenSight Biologics Ocular Gene Therapy Product and Solutions
 Table 22. GenSight Biologics Ocular Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. GenSight Biologics Recent Developments and Future Plans
 Table 24. Astellas Company Information, Head Office, and Major Competitors
 Table 25. Astellas Major Business
 Table 26. Astellas Ocular Gene Therapy Product and Solutions
 Table 27. Astellas Ocular Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. Astellas Recent Developments and Future Plans
 Table 29. Neurophth Therapeutics Company Information, Head Office, and Major Competitors
 Table 30. Neurophth Therapeutics Major Business
 Table 31. Neurophth Therapeutics Ocular Gene Therapy Product and Solutions
 Table 32. Neurophth Therapeutics Ocular Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. Neurophth Therapeutics Recent Developments and Future Plans
 Table 34. Innostellar Biotherapeutics Company Information, Head Office, and Major Competitors
 Table 35. Innostellar Biotherapeutics Major Business
 Table 36. Innostellar Biotherapeutics Ocular Gene Therapy Product and Solutions
 Table 37. Innostellar Biotherapeutics Ocular Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 38. Innostellar Biotherapeutics Recent Developments and Future Plans
 Table 39. Exegenesis Bio Company Information, Head Office, and Major Competitors
 Table 40. Exegenesis Bio Major Business
 Table 41. Exegenesis Bio Ocular Gene Therapy Product and Solutions
 Table 42. Exegenesis Bio Ocular Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 43. Exegenesis Bio Recent Developments and Future Plans
 Table 44. Zhongyin Technology Company Information, Head Office, and Major Competitors
 Table 45. Zhongyin Technology Major Business
 Table 46. Zhongyin Technology Ocular Gene Therapy Product and Solutions
 Table 47. Zhongyin Technology Ocular Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 48. Zhongyin Technology Recent Developments and Future Plans
 Table 49. Global Ocular Gene Therapy Revenue (USD Million) by Players (2019-2024)
 Table 50. Global Ocular Gene Therapy Revenue Share by Players (2019-2024)
 Table 51. Breakdown of Ocular Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 52. Market Position of Players in Ocular Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 53. Head Office of Key Ocular Gene Therapy Players
 Table 54. Ocular Gene Therapy Market: Company Product Type Footprint
 Table 55. Ocular Gene Therapy Market: Company Product Application Footprint
 Table 56. Ocular Gene Therapy New Market Entrants and Barriers to Market Entry
 Table 57. Ocular Gene Therapy Mergers, Acquisition, Agreements, and Collaborations
 Table 58. Global Ocular Gene Therapy Consumption Value (USD Million) by Type (2019-2024)
 Table 59. Global Ocular Gene Therapy Consumption Value Share by Type (2019-2024)
 Table 60. Global Ocular Gene Therapy Consumption Value Forecast by Type (2025-2030)
 Table 61. Global Ocular Gene Therapy Consumption Value by Application (2019-2024)
 Table 62. Global Ocular Gene Therapy Consumption Value Forecast by Application (2025-2030)
 Table 63. North America Ocular Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 64. North America Ocular Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 65. North America Ocular Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 66. North America Ocular Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 67. North America Ocular Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 68. North America Ocular Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 69. Europe Ocular Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 70. Europe Ocular Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 71. Europe Ocular Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 72. Europe Ocular Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 73. Europe Ocular Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 74. Europe Ocular Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 75. Asia-Pacific Ocular Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 76. Asia-Pacific Ocular Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 77. Asia-Pacific Ocular Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 78. Asia-Pacific Ocular Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 79. Asia-Pacific Ocular Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 80. Asia-Pacific Ocular Gene Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 81. South America Ocular Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 82. South America Ocular Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 83. South America Ocular Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 84. South America Ocular Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 85. South America Ocular Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 86. South America Ocular Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 87. Middle East & Africa Ocular Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 88. Middle East & Africa Ocular Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 89. Middle East & Africa Ocular Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 90. Middle East & Africa Ocular Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 91. Middle East & Africa Ocular Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 92. Middle East & Africa Ocular Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 93. Global Key Players of Ocular Gene Therapy Upstream (Raw Materials)
 Table 94. Global Ocular Gene Therapy Typical Customers


List of Figures
 Figure 1. Ocular Gene Therapy Picture
 Figure 2. Global Ocular Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Ocular Gene Therapy Consumption Value Market Share by Type in 2023
 Figure 4. Gene Replacement Technology
 Figure 5. Gene Editing Technology
 Figure 6. Others
 Figure 7. Global Ocular Gene Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 8. Ocular Gene Therapy Consumption Value Market Share by Application in 2023
 Figure 9. Hospitals Picture
 Figure 10. Diagnostics Centers Picture
 Figure 11. Research Institutes Picture
 Figure 12. Global Ocular Gene Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 13. Global Ocular Gene Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 14. Global Market Ocular Gene Therapy Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 15. Global Ocular Gene Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 16. Global Ocular Gene Therapy Consumption Value Market Share by Region in 2023
 Figure 17. North America Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 18. Europe Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 19. Asia-Pacific Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 20. South America Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 21. Middle East & Africa Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 22. Company Three Recent Developments and Future Plans
 Figure 23. Global Ocular Gene Therapy Revenue Share by Players in 2023
 Figure 24. Ocular Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 25. Market Share of Ocular Gene Therapy by Player Revenue in 2023
 Figure 26. Top 3 Ocular Gene Therapy Players Market Share in 2023
 Figure 27. Top 6 Ocular Gene Therapy Players Market Share in 2023
 Figure 28. Global Ocular Gene Therapy Consumption Value Share by Type (2019-2024)
 Figure 29. Global Ocular Gene Therapy Market Share Forecast by Type (2025-2030)
 Figure 30. Global Ocular Gene Therapy Consumption Value Share by Application (2019-2024)
 Figure 31. Global Ocular Gene Therapy Market Share Forecast by Application (2025-2030)
 Figure 32. North America Ocular Gene Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 33. North America Ocular Gene Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 34. North America Ocular Gene Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 35. United States Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 36. Canada Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 37. Mexico Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 38. Europe Ocular Gene Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 39. Europe Ocular Gene Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 40. Europe Ocular Gene Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 41. Germany Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 42. France Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 43. United Kingdom Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 44. Russia Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 45. Italy Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 46. Asia-Pacific Ocular Gene Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 47. Asia-Pacific Ocular Gene Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 48. Asia-Pacific Ocular Gene Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 49. China Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 50. Japan Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 51. South Korea Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 52. India Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 53. Southeast Asia Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 54. Australia Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 55. South America Ocular Gene Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 56. South America Ocular Gene Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 57. South America Ocular Gene Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 58. Brazil Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 59. Argentina Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 60. Middle East & Africa Ocular Gene Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 61. Middle East & Africa Ocular Gene Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 62. Middle East & Africa Ocular Gene Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 63. Turkey Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 64. Saudi Arabia Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 65. UAE Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 66. Ocular Gene Therapy Market Drivers
 Figure 67. Ocular Gene Therapy Market Restraints
 Figure 68. Ocular Gene Therapy Market Trends
 Figure 69. Porters Five Forces Analysis
 Figure 70. Ocular Gene Therapy Industrial Chain
 Figure 71. Methodology
 Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AbbVie
MeriaGTx
Regenxbio
GenSight Biologics
Astellas
Neurophth Therapeutics
Innostellar Biotherapeutics
Exegenesis Bio
Zhongyin Technology

Related Reports

Global Ocular Gene Therapy Supply, Demand and Key Producers, 2024-2030

Global Ocular Gene Therapy Supply, Demand and Key Producers, 2024-2030

date 23 May 2024

date Medical Care

The global Ocular Gene Therapy market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

Product Tags

Ocular Gene Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>